BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3839091)

  • 1. [Evaluation and perspectives of a new cephalosporin: ceftriaxone].
    Auvergnat JC; Armengaud M
    Rev Med Interne; 1985 Mar; 6(2):187-92. PubMed ID: 3839091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of ceftriaxone in the pediatric field].
    Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1984 Nov; 37(11):2027-33. PubMed ID: 6098699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of ceftriaxone.
    File TM; Tan JS; Salstrom SJ
    Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with ceftizoxime: an overall summary of clinical trials in Japan.
    Shimada J; Shimizu K
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():311-26. PubMed ID: 6296026
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftizoxime: clinical evaluation of efficacy and safety in the U.S.A.
    Parks D; Layne P; Uri J; Ziv D; Bass S
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():327-38. PubMed ID: 6296027
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of ceftriaxone in pediatric infections].
    Ohnuma M; Watanabe A
    Jpn J Antibiot; 1984 Nov; 37(11):2015-20. PubMed ID: 6098697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone therapy of serious bacterial infections.
    Eron LJ; Park CH; Goldenberg RI; Poretz DM
    J Antimicrob Chemother; 1983 Jul; 12(1):65-78. PubMed ID: 6311783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children.
    Martin E
    Eur J Clin Microbiol; 1983 Oct; 2(5):509-15. PubMed ID: 6315428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone therapy of serious bacterial infections in adults.
    Bittner MJ; Dworzack DL; Preheim LC; Tofte RW; Crossley KB
    Antimicrob Agents Chemother; 1983 Feb; 23(2):261-6. PubMed ID: 6301365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone--clinical experience in the treatment of neonates.
    James J; Mulhall A; de Louvois J
    J Infect; 1985 Jul; 11(1):25-33. PubMed ID: 4031525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.
    Maslow MJ; Levine JF; Pollock AA; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1982 Jul; 22(1):103-7. PubMed ID: 6289735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation on ceftriaxone in the field of pediatrics].
    Haruta T; Kuroki S; Mayumi M; Matsuo H; Ohkura K; Kobayashi Y
    Jpn J Antibiot; 1984 Nov; 37(11):2141-51. PubMed ID: 6098707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of cefotiam in internal medicine].
    Kawamura S; Sakata Y; Chiba Y; Yoshida Y; Aizawa M; Nara H; Yanagiya S; Fukushi K; Ohmi T; Okamoto K; Komatsu Y; Haneda Y; Tanabe K; Segawa M; Yamagata A; Kawatsu S
    Jpn J Antibiot; 1982 May; 35(5):1136-44. PubMed ID: 6290697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental and clinical evaluation of ceftriaxone in the pediatric field].
    Sunakawa K; Saitoh N; Adachibara A; Ishizuka Y; Iwata S; Satoh Y; Akita H
    Jpn J Antibiot; 1984 Nov; 37(11):2102-10. PubMed ID: 6098704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.
    Barradas P; Zamith M; Videira W; Cardosa T; Marques RA; Avila R
    Chemotherapy; 1989; 35 Suppl 2():33-40. PubMed ID: 2612238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of ceftriaxone in children].
    Terashima I; Uehara S; Toba T; Hayashi T; Hoshi M
    Jpn J Antibiot; 1984 Nov; 37(11):2021-6. PubMed ID: 6098698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Richards DM; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Jun; 27(6):469-527. PubMed ID: 6329638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ceftriaxone in serious bacterial infections.
    Epstein JS; Hasselquist SM; Simon GL
    Antimicrob Agents Chemother; 1982 Mar; 21(3):402-6. PubMed ID: 6285809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.